MPO and Alzheimer disease: The present review has systematically examined the most relevant data on some important “non-apolipoprotein” components of HDL and their involvement in AD pathogenesis, focusing on myeloperoxidase, serum amyloid A, lipoprotein phospholipase A2, glutathione peroxidase-3, and paraoxonase-3.